We report radioiodinated chalcone derivatives as new SPECT imaging probes for amyloid β (Aβ) plaques. The monoethyleneoxy derivative 2 and allyloxy derivative 8 showed a high affinity for Aβ(1-42) aggregates with Ki values of 24 and 4.5 nM, respectively. Fluorescent imaging demonstrated that 2 and 8 clearly stained thioflavin-S positive Aβ plaques in the brain sections of Tg2576 transgenic mice. In vitro autoradiography revealed that [ 125 I]2 displayed no clear accumulation toward Aβ plaques in the brain sections of Tg2576 mice, whereas the accumulation pattern of [ 125 I]8 matched with the presence of Aβ plaques both in Fuchigami et al. Page 2/28
Introduction
Alzheimer's disease (AD) is the most common form of dementia in the elderly, characterized by memory loss and cognitive dysfunction. Amyloid β (Aβ) plaques and intracellular neurofibrillary tangles in the postmortem brain have been reported to be the key pathological hallmarks of AD 1, 2 . According to the amyloid hypothesis, disruption of the balance between the production and clearance of Aβ leads to aggregation and accumulation of Aβ in the brain. This process may initiate various factors such as synaptic dysfunction for cognitive impairment in AD 3 . Non-invasive diagnostic methods, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET), are Fuchigami et al. Page 3/28 expected to be powerful tools for the detection of Aβ plaques in the early stage of AD and monitoring the efficacy of therapeutic treatments for AD patients. For these purposes, a number of Aβ plaques targeted in vivo imaging probes based on the dye staining for amyloid fibrils including thioflavin-T and Congo Red have been developed 4 . It has been demonstrated that several PET ligands could detect human brain Aβ plaques and distinguish AD patients from healthy subjects 5 . Recently, [ 18 F]florbetapir (Amyvid) and [ 18 F]flutemetamol (Vizamyl) were launched in the United States and/or Europe for the clinical evaluation of Aβ neuritic plaque density when evaluating patients with cognitive impairment 6, 7 . SPECT imaging can provide a cost-effective and convenient approach for the visualization of Aβ plaques in the brain.
Considerable effort has been devoted to the development of SPECT probes labeled with 99m Tc or 123/125 I for the Aβ plaques [8] [9] [10] [11] [12] [13] . However, none of them have been approved by the Food and Drugs Administration (FDA) and/or the European Medicines Agency (EMA).
[ 123 I]IMPY is the only SPECT imaging probe that has been used in clinical studies; however, the signal-to-noise ratio obtained for plaque labeling has been unsatisfactory 14 . Accordingly, there is real need for clinically useful SPECT probes for the detection of Aβ plaques.
We have previously reported Aβ imaging agents based on flavonoid derivatives, such as flavones 15, 16 , chalcones [17] [18] [19] [20] , aurones 21, 22 , and styrylchromones 23 , for nuclear medicine imaging as shown in Fig. 1 . Although several compounds have been demonstrated to be promising Aβ imaging probes, clinical studies of the compounds have not yet been conducted. Our previous Fuchigami et al. Page 4/28 studies demonstrated that chalcone derivatives fluoro-pegylated at the p-position of the 1phenyl ring showed a sufficient brain uptake with a good binding capacity to Aβ plaques 19 . In addition, radioiodinated flavonoids, such as flavone and aurone derivatives, with a methoxy or oligoethyleneoxy group at the p-position of the 3-phenyl ring have the properties of high brain uptake and rapid clearance from the brain without significant decrease in the binding affinity for Aβ 15, 22 . On the basis of the results of these studies, we hypothesized that the introduction of ethyleneoxy groups at the p-position of the 3-phenyl ring or iodoallyloxy group at the p-position of the 1-phenyl ring in the chalcone derivatives could improve the binding affinity for the Aβ plaques and/or brain distribution pattern. In this paper, we report the additional structural modification of chalcone derivatives to discover useful imaging probes for Aβ plaques.
Results and discussion

Chemistry
The target chalcone derivatives were synthesized according to the procedure shown in Scheme 1. 4-Iodoacetophenone was reacted with 4-methoxybenzaldehyde in the presence of a basic catalyst (10% KOH) in ethanol at room temperature to form 4'-iodo-4-methoxychalcone 1 in quantitative yield. Direct alkylation of 1 with ethylene chlorohydrin, ethylene glycol mono-2-chloroethyl ether, or 2-[2-(2-chloroethoxy)ethoxy]ethanol with potassium carbonate in DMF provided 2, 3 and 4 for yields of 52, 49 and 17%, respectively. The tributyltin derivative 5 was prepared from the corresponding iodo derivative 4 using a iodo-totributyltin exchange reaction catalyzed by Pd(0) for a yield of 48%. The starting material 6 for the synthesis of the allyoxylated chalcone derivative 8 was prepared as previously reported 20 .
The p-toluenesulfonate ester of (E)-3-(tri-n-butylstannyl)prop-2-enol 24 was coupled with the phenol 6 to produce the tributyltin derivative 7 in a yield of 45%. Compound 7 was reacted with iodine in CHCl3 to form the target 8 (62% yield).
In vitro binding assays using Aβ1-42 aggregates
In vitro binding experiments to evaluate the binding affinity of the chalcones for Aβ were between the binding affinity and length of the oligoethyleneoxy group of the chalcones was similar to that of the aurone derivatives 22 . On the other hand, the allyloxy derivative 8 showed excellent binding affinity for Aβ (Ki= 4.5 nM), which is stronger than that of DMIC (Ki= 10.8 nM). Based on these in vitro results, we selected the monoethyleneoxy derivative 2 and allyloxy derivative 8 for further experiments.
Fluorescence staining on Tg2576 mice brain sections
Fluorescence imaging experiments of the chalcones 2 and 8 were performed using brain slices from Aβ deposition model transgenic mice (Tg2576 mice). A number of fluorescence spots of 2 and 8 were observed in the brain slices of the Tg2576 mice ( Figs. 2A and D) . The labeling patterns of these compounds corresponded to the fluorescence signals obtained by thioflavin-S (Figs. 2B and E). In the wild-type mice brain, there was no significant fluorescence of 2 and 8 (Figs. 2C and F). The autofluorescence of the adjacent brain slices used in the assays was also examined. Significant fluorescence was not observed in any of the slices. These results indicated that 2 and 8 have specific binding potential to Aβ plaques in the mice brain.
In vitro autoradiography
The radioiodinated chalcones [ 125 I]2 and [ 125 I]8 were prepared by an iododestannylation On the other hand, this difference might be related to the binding affinity of the chalcone derivatives for the Aβ aggregates; 8 showed a 5.3-fold lower Ki value than 2 (Table 1) . Indeed, it was reported that several Aβ probes with single-digit nanomolar Ki values for the Aβ aggregates successfully stained the Aβ plaques in brain sections of the Tg2576 mice by in vitro autoradiography 25, 26 . In addition, it has been shown that chalcone derivatives with a dimethylamino group at the third position can be used to visualize Aβ plaques by in vitro autoradiography 19, 27 . Thus, chalcone derivatives with a dimethylamino group in the 3-phenyl ring may be more suitable than those with an alkoxy group with respect to binding of the Aβ plaques in the brain.
To further characterize the binding property of [ 125 I]8 for the Aβ plaques, the in vitro 
In vivo biodistribution stuides
To develop prospective in vivo imaging probes for Aβ, a high initial brain uptake and rapid clearance from the brain are two important requirements. Therefore, biodistribution studies of [ 125 I]2 and [ 125 I]8 were performed in normal mice and expressed as % of injected dose per gram (%ID/g) ( Table 2 ). [ 125 I]2 showed a high initial uptake (4.82%ID/g at 2 min) and rapid clearance from the brain (0.45%ID/g at 60 min). On the other hand, [ 125 I]8 showed a modest brain uptake (1.62%ID/g at 2 min) and relatively slow clearance from the brain (0.56%ID/g at 60 min). The ratio brain2 min/brain60 min is considered to be an important index 
Experimental
General information
All reagents were commercial products and used without further purification unless otherwise indicated. Na[ 125 ]I was obtained from MP Biomedicals (Costa Mesa, CA, USA). The 1 H NMR spectra were obtained using a Varian Gemini 300 spectrometer with TMS as the internal standard. The mass spectra were obtained using JMS -700N or JMS-T100TD instruments (JEOL, Japan). The HPLC analysis was performed by a Shimadzu HPLC system (LC-10AT pump with SPD-10A UV detector, λ= 254 nm). An automated gamma counter with Fuchigami et al. Page 11/28 a NaI(Tl) detector (Perkin-Elmer, 2470 WIZARD 2 ) was used to measure the radioactivity. 4-Dimethylamino-4'-iodo-chalcone (DMIC) and [ 125 I]DMIC were prepared by the method in the literature 10 . The AD transgenic mice (Tg2576, C57BL6, APPsw) were purchased from Taconic Farms, Inc. All animals were supplied by the Tagawa Experimental Animal Laboratory (Nagasaki, Japan). The experiments with animals were conducted in accordance with our institutional guidelines and were approved by the Nagasaki University Animal Care Committee.
(E)-1-(4-Iodophenyl )-3-(4-methoxyphenyl)prop-2-en-1-one (1)
4-Iodoacetophenone (2.46 g, 10 mmol) and 4-anisaldehyde (1.2 mL, 10 mmol) were dissolved in 20 mL of ethanol. The mixture was allowed to stir for 15 min in an ice bath. A 30 mL aliquot of 10% aqueous potassium hydroxide solution was then slowly added dropwise into the reaction mixture. The reaction solution was allowed to stir at room temperature for 4 h. A precipitate was collected and washed with ethanol to provide 3.69 g of 1 (quant). 1 
(E)-3-(4-(2-Hydroxyethoxy)phenyl)-1-(4-iodophenyl)prop-2-en-1-one (2)
To a solution of compound 1 (120 mg, 0.34 mmol) in DMF (2 mL) was added 2-Fuchigami et al. Page 12/28 chloroethanol (45 µL, 0.34 mmol) and K2CO3 (138 mg, 1.02 mmol). The mixture was heated at 80 ˚C for 13 h. After cooling the reaction mixture, the solvent was quenched by H2O and extracted three times with EtOAc. The combined organic layer was washed with brine. After drying over Na2SO4, the solvent was removed and the crude product was chromatographed on silica gel with hexane/EtOAc= 1:1 to give 5 (70 mg, 52%) as a yellow solid. 1 
(E)-3-(4-(2-(2-Hydroxyethoxy)ethoxy)phenyl)-1-(4-iodophenyl)prop-2-en-1-one (3)
Using the above procedure for 2 starting from compound 1 and 2- 
(E)-3-(4-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)phenyl)-1-(4-iodophenyl)prop-2-
(E)-3-(4-(2-Hydroxyethoxy)phenyl)-1-(4-tributylstannylphenyl)prop-2-en-1-one (5)
A mixture of 2 (58 mg, 0.15 mmol), bis(tributyltin) (0.12 mL, 0.24 mmol) and Pd(PPh3)4 
(E)-3-(4-(dimethylamino)phenyl)-1-(4-(((E)-3-(tributylstannyl)allyl)oxy)phenyl)
prop-2-en-1-one (7)
To a solution of compound 6 13 
(E)-3-(4-(dimethylamino)phenyl)-1-(4-(((E)-3-iodoallyl)oxy)phenyl)prop-2-en-1one (8)
To a solution of 7 (22.2 mg, 0.037 mmol) in CHCl3 (5.0 mL) was added a solution of iodine in CHCl3 (2.0 mL, 0.25 M) at room temperature. The mixture was stirred at room temperature for 30 min and a saturated NaHSO3 solution (10 mL) was added. The mixture was stirred for 5 min and the organic phase was separated. The aqueous layer was extracted three times with CHCl3. The organic layer was successively washed with saturated aqueous NaHCO3 
Radioiodination
The 
Binding assays using the aggregated Aβ peptide in solution
Binding assays by using filtration techniques were carried out as described previously 10 .
A solid form of Aβ(1-42) was purchased from Peptide Institute (Osaka, Japan). 
Fluorescence staining on Tg2576 mice brain sections
The Tg2576 mice (female, 22-month-old) and wild-type mice (female, 22-month-old)
were used as the Alzheimer's model and control mice, respectively. After the mice were sacrificed by decapitation, the brains were immediately removed and frozen in powdered dry Thereafter, the serial sections were also stained with thioflavin S, a pathological dye commonly used for staining Aβ plaques in the brain, and examined using the microscope in the same condition with that of chalcones.
In vitro autoradiography on Tg2576 mice brain sections
The Inc. The presence and localization of plaques on the sections were confirmed by immunohistochemical staining using the monoclonal antibody BC05 (Wako) as already reported 31 . 
In vivo biodistribution in normal mice
Statistical analysis
Statistical significance was determined at p<0.05 using the one way analysis of variance for comparison of more than two means, followed by post hoc tests using Bonferroni's correction.
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